MB49-Luc Cells
CAD$1,104.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | MB49-Luc is a bioluminescent derivative of the murine MB49 bladder transitional cell carcinoma cell line, engineered to stably express a firefly luciferase reporter gene. The parental MB49 cell line was originally induced by 7,12-dimethylbenz[a]anthracene (DMBA) in a C57BL/6 mouse and is widely used as a syngeneic model of urothelial carcinoma in immunocompetent C57BL/6 hosts. MB49 cells exhibit epithelial morphology and express MHC class I antigens, making them immunologically recognizable by the host immune system and therefore a valuable model for studying tumor-immune interactions, immunotherapy approaches, and immune escape mechanisms in bladder cancer. The stable luciferase integration in MB49-Luc enables sensitive, noninvasive bioluminescence imaging (BLI) of tumor burden in orthotopic intravesical and subcutaneous models in syngeneic C57BL/6 mice. The emitted signal correlates with viable tumor cell number, supporting longitudinal assessment of tumor engraftment, bladder tumor progression, and therapeutic response without repeated invasive procedures. MB49-Luc is particularly valuable for evaluating intravesical immunotherapy regimens, systemic checkpoint inhibitors, and novel therapeutic modalities for muscle-invasive and non-muscle-invasive bladder cancer in immunocompetent preclinical models. MB49-Luc retains the core biological and immunological features of the parental MB49 line, including its C57BL/6 syngeneic compatibility and characteristic karyotypic feature of chromosome Y loss. The luciferase reporter enhances experimental sensitivity and enables real-time tumor tracking. Researchers should confirm luciferase activity, growth kinetics, and immunological phenotype under their specific experimental conditions prior to large-scale in vivo use. |
|---|---|
| Organism | Mouse |
| Tissue | Urinary bladder |
| Disease | Mouse bladder transitional cell carcinoma |
| Synonyms | MB49-luciferase, MB49 LucSH+ |
Characteristics
| Age | Adult |
|---|---|
| Gender | Male |
| Ethnicity | Inbred mouse strain (C57BL/6) |
| Morphology | Epithelial |
| Growth properties | Adherent |
Regulatory Data
| Citation | MB49-Luc (Cytion catalog number 305681) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_E8D4 |
| GMO Status | GMO-S1: This MB49 bladder carcinoma mouse line contains a-Luc reporter cassette for tumor progression imaging. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Protein expression | Luc |
|---|---|
| Karyotype | Has lost chromosome Y |
Handling
| Culture Medium | DMEM |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Doubling time | 24-48 hours |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Split ratio | 1 to 3 |
| Seeding density | 1 to 3 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
-
Related products
Related products
MB49-Luc CellsOrganism Mouse Tissue Urinary bladder Disease Mouse bladder transitional cell carcinoma CAD$1,104.00*Neuro2a-Luc CellsOrganism Mouse Tissue Peripheral nervous system Disease Neuroblastoma CAD$1,104.00*Panc02-Luc CellsOrganism Mouse Tissue Pancreas Disease Mouse pancreatic ductal adenocarcinoma CAD$1,104.00*HeLa-Luc CellsOrganism Human Tissue Uterus, cervix Disease Human papillomavirus-related endocervical adenocarcinoma CAD$1,104.00*